ORF Biologics

ORF Biologics delivers custom and off-the-shelf biologics, including proteins, peptides, antibodies, and cell media.

Health and bioData and analyticsCommerce and retail

ORF Biologics has no funding amount on record yet; its latest known round is Seed (Jul 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. July 31, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related data analytics companies

• YYOUnifiedAISep 24, 2026
• AAzulene Labs$3.4M · Sep 23, 2026
• EEkai$1.7M · Sep 23, 2026
• Mmicro1$100M · Sep 23, 2026
• RRelaiSantéSep 22, 2026
• YYNOS$252K · Sep 22, 2026
• SSeattle Neurosound SolutionsSep 21, 2026
• HHypestats$45M · Sep 17, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/orf-biologics.